دورية أكاديمية

The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) III Randomized Controlled Trial.

التفاصيل البيبلوغرافية
العنوان: The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) III Randomized Controlled Trial.
المؤلفون: Upshaw JN; The CardioVascular Center, Tufts Medical Center, Boston, MA. Electronic address: jupshaw@tuftsmedicalcenter.org., Parker S; New England Quality Care Alliance, Braintree, MA., Gregory D; Cardiovascular Clinical Studies, Boston MA., Koethe B; Biostatics, Epidemiology, and Research Design Center, Tufts Medical Center, Boston MA., Vest AR; The CardioVascular Center, Tufts Medical Center, Boston, MA., Patel AR; The CardioVascular Center, Tufts Medical Center, Boston, MA., Kiernan MS; The CardioVascular Center, Tufts Medical Center, Boston, MA., DeNofrio D; The CardioVascular Center, Tufts Medical Center, Boston, MA., Davidson E; Heart Center of Metrowest, Framingham MA., Mohanty S; The CardioVascular Center, Tufts Medical Center, Boston, MA., Arpin P; The CardioVascular Center, Tufts Medical Center, Boston, MA., Strauss N; The CardioVascular Center, Tufts Medical Center, Boston, MA., Sommer C; The CardioVascular Center, Tufts Medical Center, Boston, MA., Brandon L; New England Quality Care Alliance, Braintree, MA., Butler R; The CardioVascular Center, Tufts Medical Center, Boston, MA., Dwaah H; Tufts University School of Medicine, Boston, MA., Nadeau H; New England Quality Care Alliance, Braintree, MA., Cantor M; New England Quality Care Alliance, Braintree, MA., Konstam MA; The CardioVascular Center, Tufts Medical Center, Boston, MA.
المصدر: American heart journal [Am Heart J] 2023 Jun; Vol. 260, pp. 90-99. Date of Electronic Publication: 2023 Feb 25.
نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE
أسماء مطبوعة: Original Publication: St. Louis, MO : Mosby
مواضيع طبية MeSH: Telemedicine* , Heart Failure*, Humans ; Hospitalization ; Telephone ; Computers, Handheld ; Disease Management
مستخلص: Background: Mobile health applications are becoming increasingly common. Prior work has demonstrated reduced heart failure (HF) hospitalizations with HF disease management programs; however, few of these programs have used tablet computer-based technology.
Methods: Participants with a diagnosis of HF and at least 1 high risk feature for hospitalization were randomized to either an established telephone-based disease management program or the same disease management program with the addition of remote monitoring of weight, blood pressure, heart rate and symptoms via a tablet computer for 90 days. The primary endpoint was the number of days hospitalized for HF assessed at 90 days.
Results: From August 2014 to April 2019, 212 participants from 3 hospitals in Massachusetts were randomized 3:1 to telemonitoring-based HF disease management (n = 159) or telephone-based HF disease management (n = 53) with 98% of individuals in both study groups completing the 90 days of follow-up. There was no significant difference in the number of days hospitalized for HF between the telemonitoring disease management group (0.88 ± 3.28 days per patient-90 days) and the telephone-based disease management group (1.00 ± 2.97 days per patient-90 days); incidence rate ratio 0.82 (95% confidence interval, 0.43-1.58; P = .442).
Conclusions: The addition of tablet-based telemonitoring to an established HF telephone-based disease management program did not reduce HF hospitalizations; however, study power was limited.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
References: J Card Fail. 2011 Feb;17(2):151-7. (PMID: 21300305)
N Engl J Med. 2010 Dec 9;363(24):2301-9. (PMID: 21080835)
Am Heart J. 2003 Oct;146(4):705-12. (PMID: 14564327)
J Am Coll Cardiol. 2005 May 17;45(10):1654-64. (PMID: 15893183)
Circulation. 2004 Sep 14;110(11):1450-5. (PMID: 15313938)
Heart. 2020 Oct;106(20):1573-1578. (PMID: 32580977)
Ann Intern Med. 2006 Aug 15;145(4):273-83. (PMID: 16908918)
Circulation. 2014 Sep 16;130(12):966-75. (PMID: 25135276)
JBI Database System Rev Implement Rep. 2016 Jan;14(1):210-47. (PMID: 26878928)
Eur J Cardiovasc Nurs. 2014 Jun;13(3):243-52. (PMID: 23630403)
N Engl J Med. 1995 Nov 2;333(18):1190-5. (PMID: 7565975)
J Cardiovasc Nurs. 2009 Nov-Dec;24(6):485-97. (PMID: 19786884)
J Card Fail. 2010 Apr;16(4):285-92. (PMID: 20350694)
Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004755. (PMID: 30562068)
J Telemed Telecare. 2008;14(6):300-5. (PMID: 18776075)
Circulation. 2020 Mar 3;141(9):e139-e596. (PMID: 31992061)
Cochrane Database Syst Rev. 2015 Oct 31;(10):CD007228. (PMID: 26517969)
Neth Heart J. 2019 Nov;27(11):565-574. (PMID: 31414308)
J Clin Epidemiol. 1998 Nov;51(11):1171-8. (PMID: 9817135)
BMC Health Serv Res. 2006 Mar 13;6:30. (PMID: 16533388)
J Am Coll Cardiol. 2010 Jul 27;56(5):372-8. (PMID: 20650358)
J Am Coll Cardiol. 2018 Jun 12;71(23):2643-2652. (PMID: 29880124)
Circulation. 2011 May 3;123(17):1873-80. (PMID: 21444883)
معلومات مُعتمدة: K08 HL146959 United States HL NHLBI NIH HHS; TL1 TR002546 United States TR NCATS NIH HHS
سلسلة جزيئية: ClinicalTrials.gov NCT02084992
تواريخ الأحداث: Date Created: 20230226 Date Completed: 20230508 Latest Revision: 20240626
رمز التحديث: 20240626
مُعرف محوري في PubMed: PMC11195537
DOI: 10.1016/j.ahj.2023.02.007
PMID: 36842486
قاعدة البيانات: MEDLINE
الوصف
تدمد:1097-6744
DOI:10.1016/j.ahj.2023.02.007